Assessment of selection and resistance risk for demethylation inhibitor fungicides in Aspergillusfumigatus in agriculture and medicine: A critical review

Pest Management Science

Volumn 70, Issue 3, 2014, Pages 352-364

  Gisi, Ulrich ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Agricultural fungicides; Aspergillus; Azole fungicides; DMI fungicides; DMI resistance; Exposure concentrations; Medical fungicides; Pathogen exposure risk; Selection risk; Veterinary fungicides

Indexed keywords

ANTIFUNGAL AGENT; FUNGICIDE;

ANIMAL; ANTIFUNGAL RESISTANCE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; METHYLATION; MICROBIOLOGY; PLANT DISEASE; REVIEW;

ANIMALS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; DRUG RESISTANCE, FUNGAL; FUNGICIDES, INDUSTRIAL; HUMANS; METHYLATION; PLANT DISEASES;

EID: 84895067977     PISSN: 1526498X     EISSN: 15264998     Source Type: Journal    
DOI: 10.1002/ps.3664     Document Type: Review

References (64)

1. Domsch KH, Gams W and Anderson T-H, Compendium of Soil Fungi, Vol. 1. Academic Press, London (1980).
2. Dagenais TRT and Keller NP, Pathogenesis of Aspergillusfumigatus in invasive Aspergillosis. Clin Microbiol Rev 22:447-465 (2009).
3. Schmidt S, http://www.allum.de/stoffe-und-ausloeser/schimmelpilze/schimmelpilzbelastung-der-aussenluft-und-im-innenraum (2012).
4. Engelhart S, Simon A and Exner M, New RKI-KRINKO recommendation for immuno-compromised patients: grading of immunosuppression, hospital ventilation requirements and infection prevention in the domestic environment. Umweltmed Forsch Prax 15(2):92-98 (2010) (in German).
5. Rhodes JC, Aspergillusfumigatus: growth and virulence. Med Mycol 44:77-81 (2006).
6. Scheer C, Nachweis von Aspergillus-fumigatus-Infektionen aus dem Respirationstrakt mittels TaqMan-PCR. Dissertation Medizinische Fakultät der Charité-Universität Berlin (2006) (in German).
7. Eggimann P, Chevrolet J-C, Starobinski M, Majno P, Totsch M, Chapuis B, etal, Primary invasive Aspergillosis of the digestive tract: report of two cases and review of the literature. Infection 34:333-338 (2006).
8. Saunders JH, Duchateau L, Stark C and Van Bree H, Noninvasive intranasal infusion of enilconazole in dogs with nasal Aspergillosis. Veterinary mycoses, a treatment protocol - nasal Aspergillosis. Can Vet J 1-7 (2003).
9. Vanden Bossche H, Engelen, M and Rochette F, Antifungal agents of use in animal health - chemical, biochemical and pharmacological aspects. J Vet Pharmacol Ther 26:5-29 (2003).
10. Fischer G, Muller T, Ostrowski R and Dott W, Mycotoxins of Aspergillusfumigatus in pure culture and in native bioaerosols from composting facilities. Chemosphere 38:1745-1755 (1999).
11. Kosalec I and Pepeljnjak S, Mycotoxigenicity of clinical and environmental Aspergillusfumigatus and A.flavus isolates. Acta Pharmaceut 55:365-375 (2005).
12. Kuck KH, Stenzl K and Vors J-P, Sterol biosynthesis inhibitors, in Modern Crop Protection Compounds, Vol. 2. Fungicides, ed. by Krämer W, Schirmer U, Jeschke P and Witschel M, 2nd rev. edn. Wiley-VCH Verlag, Weinheim, pp. 761-805 (2012).
13. Snelders E, Camps SMT, Karawajczyk A, Schaftenaar G, Kema GHJ, Van der Lee HA, etal, Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillusfumigatus. PLoS One 7(3):e31801, 1-11 (2012).
14. Sierotzki H and Gisi U, Molecular diagnostics for fungicide resistance in plant pathogens, in Chemistry of Crop Protection, ed. by Voss G and Ramos G. Wiley-VCH, Weinheim, pp. 71-88 (2003).
15. Gisi U and Sierotzki H, Molecular and genetic aspects of fungicide resistance in plant pathogens, in Modern Fungicides and Antifungal Compounds V, ed. by Dehne HW, Deising HB, Gisi U, Kuck KH, Russell PE and Lyr H. DPG Selbstverlag, Braunschweig, pp. 53-56 (2008).
16. Meneau I and Sanglard D, Azole and fungicide resistance in clinical and environmental Aspergillusfumigatus isolates. Med Mycol 43(Suppl 1):307-311 (2005).
17. Helmerhorst EJ, Reijnders IM, Van't Hof W, Simoons-Smit I, Veerman ECI and Nieuw Amerongen AV, Amphotericin B- and fluconazole-resistant Candida spp., Aspergillusfumigatus and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides. Antimicrob Agent Chemother 43:702-704 (1999).
18. Hof H, Multiresistente Pilze. Ein neuer Grund für Isolierung von Patienten? Vortrag am Forum Hygiene und Infektiologie, Leipzig (2010) (in German).
19. Moore CB, Sayers N, Mosquera J, Slaven J and Denning DW, Antifungal drug resistance in Aspergillus. J Infect 41:203-220 (2000).
20. Snelders E, Van der Lee HAL, Kuijpers J, Rijs AJMM, Varga J, Samson RA, etal, Emergence of azole resistance in Aspergillusfumigatus and spread of a single resistance mechanism. PLoS Med 5(11):e219, 1629-1637 (2008).
21. Howard SJ, Cerar D, Anderson MJ, Albarraga A, Fisher MC, Pasqualotto AC, etal, Frequency and evolution of azole resistance in Aspergillusfumigatus associated with treatment failure. Emerg Infect Dis 15:1068-1076 (2009).
22. Arendrup MC, Mavridou E, Mortensen KL, Snelders E, Frimodt-Moller N, Khan H, etal, Development of azole resistance in Aspergillusfumigatus during azole therapy associated with change in virulence. PLoS One 5(4):e10080, 1-8 (2010).
23. Verweij PE, Snelders E, Kema GH, Mellado E and Melchers WJ, Azole resistance in Aspergillusfumigatus: a side-effect of environmental fungicide use? Lancet Infect Dis 9:789-795 (2009).
24. Snelders E, Huis in't Veld RAG, Rijs AJMM, Kema GHJ, Melchers WJG and Verweij PE, Possible environmental origin of resistance of Aspergillusfumigatus to medical triazoles. Appl Environ Microb 75:4053-4057 (2009).
25. Mortensen KL, Mellado E, Lass-Flörl C, Rodriguez-Tudela JL, Johansen HK and Arendrup MC, Environmental study of azole-resistant Aspergillusfumigatus and other Aspergilli in Austria, Denmark and Spain. Antimicrob Agent Chemother 54:4545-4549 (2010).
26. Verweij PE, Van de Sande-Bruisma N, Kema GH and Melchers WJ, Azole resistance in Aspergillusfumigatus in the Netherlands - increase due to environmental fungicides? Ned Tijdschr Geneeskd 156: A4458 (2012) (in Dutch).
27. Xiao L, Madison V, Chau AS, Loebenberg D, Palermo RE and McNicholas PM, Three-dimensional models of wild-type and mutated forms of cytochrome P450 14α-sterol demethylases from Aspergillusfumigatus and Candidaalbicans provide insights into posaconazole binding. Antimicrob Agent Chemother 48:568-574 (2004).
28. Qiao J, Liu W and Li R, Antifungal resistance mechanisms of Aspergillus. Jpn J Med Mycol 49:157-163 (2008).
29. Verweij PE, Oakley KL, Morrissey J, Morrissey G and Denning DW, Efficacy of LY303366 against amphotericinB-susceptible and -resistant Aspergillusfumigatus in a murine model of invasive Aspergillosis. Antimicrob Agent Chemother 42:873-878 (1998).
30. Browne ML, Ju CL, Recer GM, Kallenbach LR, Melius JM and Horn, EG, A prospective study of health symptoms and Aspergillusfumigatus spore counts near a grass and leaf composting facility. Compost Sci Util 9:241-249 (2001).
31. Becker N, http://www.dhbv.de/dokumente/upload/b807d_der_schimmelpilz_aspergillus_fumigatus_4-2009.pdf (2009).
32. Hnilica KA and Medleau L, Evaluation of topically applied enilconazole for the treatment of dermatophytosis in a Persian cattery. Vet Dermatol 13:23-28 (2002).
33. Anonymus, http://www.vetpharm.uzh.ch
34. Patterson TF, Miniter P and Andriole VT, Efficacy of fluconazole in experimental invasive aspergillosis. Rev Infect Dis 12:281-285 (1990).
35. Anonymus, http://medikamente.onmeda.de
36. Gabrio T, Innenraum relevante Schimmelpilze in Luftproben. Umwelt Medizin Gesellschaft, umg 3/2010, Landesgesundheitsamt, Baden-Würtemberg (2010) (in German).
37. Vanhee LME, Perman D, Nelis HJ and Coenye T, Rapid quantification of itraconazole-resistant Aspergillusfumigatus in air. J Microbiol Method 81:197-199 (2010).
38. Russell PE, Sensitivity Baselines in Fungicide Resistance Research and Management FRAC Monograph No. 3. Crop Life International, Brussels (2004); and Anonymus, www.frac.info, FRAC Code List (2013).
39. Chassot C, Hugelshofer U, Sierotzki H and Gisi U, Sensitivity of cyp51 genotypes to DMI fungicides in Mycosphaerella graminicola, in Modern Fungicides and Antifungal Compounds V ed. by Dehne HW, Deising HB, Gisi U, Kuck KH, Russell PE and Lyr H. 15th International Reinhardsbrunn Symposium, Friedrichroda. DPG Selbstverlag, Braunschweig, pp. 129-136 (2008).
40. 34/L98H mutations in the cyp51A gene in India. J Antimicrob Chemother 67:362-366 (2012).
41. Liu W, Lionakis MS, Lewis RE, Wiederhold N, May GS and Kontoyiannis DP, Attenuation of itraconazole fungicidal activity following preexposure of Aspergillusfumigatus to fluconazole. Antimicrob Agent Chemother 47:3592-3597 (2003).
42. Fraaije BA, Cools HJ, Kim S-H, Motteram J, Clark WS and Lucas JA, A novel substitution I381V in the sterol 14α-demethylase (CYP51) of Mycosphaerellegraminicola is differentially selected by azole fungicides. Mol Plant Pathol 8:245-254 (2007).
43. Cools HJ and Fraaije BA, Update on mechanisms of azole resistance in Mycosphaerellagraminicola and implications for future control. Pest Manag Sci 69:150-155 (2013).
44. Morio F, Loge C, Besse B, Hennequin C and Le Pape P, Screening for amino acid substitutions in the Candidaalbicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature. Diagn Microbiol Infec Dis 66:373-384 (2010).
45. Warrilow AGS, Mullins JGL, Hull CM, Parker JE, Lamb DC, Kelly DE, etal, S279 point mutations in Candidaalbicans sterol 14α-demethylase (CYP51) reduce invitro inhibition by fluconazole. Antimicrob Agent Chemother 56:2099-2107 (2012).
46. Edlind TD, Henry KW, Metera KA and Katiyar SK, Aspergillusfumigatus CYP51 sequence: potential basis for fluconazole resistance. Med Mycol 39:299-302 (2001).
47. Stensvold C, Jørgensen L and Arendrup M, Azole-resistant invasive Aspergillosis: relationship to agriculture. Curr Fung Infect Rep 6:178-191 (2012).
48. Martel CM, Parker JE, Warrilow AG, Rolley NJ, Kelly SL and Kelly DE, Complementation of a Saccharomycescerevisiae ERG11/CYP51 (sterol 14α-demethylase) doxycycline-regulated mutant and screening of the azole sensitivity of Aspergillusfumigatus isoenzymes CYP51A and CYP51B. Antimicrob Agent Chemother 54:4920-4923 (2010).
49. Fan J, Urban M, Parker JE, Brewer HC, Kelly SL, Hammond-Kosack KE, etal, Characterization of the sterol 14α-demethylases of Fusariumgraminearum identifies a novel genus-specific CYP51 function. New Phytol 198:821-835 (2013).
50. Van der Linden JWM, Camps SMT, Kampinga GA, Arends JPA, Debets-Ossenkopp YJ, Haas PJA, etal, Aspergillosis due to voriconazole highly resistant Aspergillusfumigatus and recovery of genetically related resistant isolates from domiciles. Clin Infec Dis 57:513-520 (2013).
51. Zhu J, Xie Q and Li H, Occurrence of imazalil-resistant biotype of Penicilliumdigitatum in China and the resistant molecular mechanism. J Zhejiang University Science A 7(Suppl):362-365 (2006).
52. Sun X, Wang J, Feng D, Ma Z and Li H, PdCYP51B, a new putative sterol 14α-demethylase gene of Penicilliumdigitatum involved in resistance to imazalil and other fungicides inhibiting ergosterol synthesis. Appl Microbiol Biotechnol 91:1107-1119 (2011).
53. Zwiers L-H, Stergiopoulos I, Van Nistelrooy JGM and De Waard MA, ABC tansporters and azole susceptibility in laboratory strains of the wheat pathogen Mycosphaerellagraminicola. Antimicrob Agent Chemother 46:3900-3906 (2002).
54. Gisi U, Schenker R, Schulin R, Stadelmann FX and Sticher H, Bodenökologie, 2nd edn. Georg Thieme Verlag, Stuttgart, (1997) (in German).
55. Verweij PE, Melchers WJG and Kema GHJ, Azole resistance in Aspergillusfumigatus: collateral damage of fungicide use?, in Modern Fungicides and Antifungal Compounds VI, ed. by Dehne HW, Deising HB, Gisi U, Kuck KH, Russell PE and Lyr H, 16th International Reinhardsbrunn Symposium, Friedrichroda. DPG Selbstverlag, Braunschweig, pp. 301-305 (2011).
56. Anonymus, Pesticide Residues in Food. FAO-WHO meeting report, Plant Production and Protection Paper 191. WHO, Geneva (2007).
57. EPA Report http://cfr.vlex.com/vid/prothioconazole-tolerances-for-residues-285381831 (2010).
58. Halley JM, Robinson CH, Comins HM and Dighton J, Predicting straw decomposition by a four-species fungal community: a cellular automaton model. J Appl Ecol 33:493-507 (1996).
59. Anonymus, http://www.ages.at/ages/ernaehrungssicherheit/rueckstaende-kontaminanten/pflanzenschutzmittel-rueckstaende-in-lebensmittel/zitrusfruechte-untersuchungen/ (2007).
60. Townsend TG and Solo-Gabriele H (eds), Environmental Impacts of Treated Wood. CRC Press, Boca Rota, FL (2006).
61. Lebow, ST, Wood preservation, in Wood Handbook: Wood as an Engineering Material. General technical report FPL, GTR-190. USDA, Forest Service, Forest Products Laboratory, Madison, WI, pp. 15.1-15.28 (2010).
62. Schultz TP and Nicholas DD, Long-term outdoor efficacy trials of wood treated with organic biocides and co-added non-biocidal additives. Proceedings of the 104th Annual Meeting of the American Wood Protection Association, 104:96-102 (2008).
63. Van Cutsem J, Antifungal activity of enilconazole on experimental aspergillosis in chickens. Avian Dis 27:36-42 (1982).
64. Becher R and Wirsel SGR, Fungal cytochrome P450 sterol 14α-demethylase (CYP51) and azole resistance in plant and human pathogens. Appl Microbiol Biotech 95:825-840 (2012).